nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—DHFR—malaria	0.352	1	CbGaD
Methotrexate—DHFR—Pyrimethamine—malaria	0.155	0.367	CbGbCtD
Methotrexate—DHFR—Proguanil—malaria	0.124	0.293	CbGbCtD
Methotrexate—SLC22A11—Doxycycline—malaria	0.0348	0.0824	CbGbCtD
Methotrexate—SLC22A8—Doxycycline—malaria	0.0202	0.0479	CbGbCtD
Methotrexate—SLCO1A2—Quinine—malaria	0.0158	0.0374	CbGbCtD
Methotrexate—SLC22A6—Doxycycline—malaria	0.0141	0.0334	CbGbCtD
Methotrexate—SLCO1A2—Quinidine—malaria	0.0139	0.0329	CbGbCtD
Methotrexate—SLCO1B1—Quinidine—malaria	0.0131	0.031	CbGbCtD
Methotrexate—SLC22A8—Quinidine—malaria	0.0121	0.0286	CbGbCtD
Methotrexate—ABCC2—Quinidine—malaria	0.0115	0.0273	CbGbCtD
Methotrexate—ABCB1—Quinine—malaria	0.00427	0.0101	CbGbCtD
Methotrexate—ABCB1—Quinidine—malaria	0.00375	0.00889	CbGbCtD
Methotrexate—Pralatrexate—DHFR—malaria	0.00176	0.556	CrCbGaD
Methotrexate—Pemetrexed—DHFR—malaria	0.00141	0.444	CrCbGaD
Methotrexate—FOLR1—saliva-secreting gland—malaria	0.00135	0.0229	CbGeAlD
Methotrexate—ATIC—blood plasma—malaria	0.00132	0.0224	CbGeAlD
Methotrexate—FOLR1—hematopoietic system—malaria	0.00129	0.0219	CbGeAlD
Methotrexate—SLC19A1—hematopoietic system—malaria	0.00113	0.0192	CbGeAlD
Methotrexate—FOLR1—kidney—malaria	0.00106	0.0179	CbGeAlD
Methotrexate—MTHFR—blood plasma—malaria	0.000978	0.0166	CbGeAlD
Methotrexate—GGH—saliva-secreting gland—malaria	0.000897	0.0152	CbGeAlD
Methotrexate—SLC46A1—hematopoietic system—malaria	0.00087	0.0148	CbGeAlD
Methotrexate—FOLR1—blood—malaria	0.000853	0.0145	CbGeAlD
Methotrexate—PGD—blood plasma—malaria	0.00085	0.0144	CbGeAlD
Methotrexate—FPGS—saliva-secreting gland—malaria	0.000789	0.0134	CbGeAlD
Methotrexate—SLC19A1—digestive system—malaria	0.000785	0.0133	CbGeAlD
Methotrexate—SLCO1B1—blood plasma—malaria	0.000772	0.0131	CbGeAlD
Methotrexate—FPGS—hematopoietic system—malaria	0.000753	0.0128	CbGeAlD
Methotrexate—SLC19A1—blood—malaria	0.000748	0.0127	CbGeAlD
Methotrexate—ABCC3—blood plasma—malaria	0.000732	0.0124	CbGeAlD
Methotrexate—ATIC—hematopoietic system—malaria	0.000728	0.0124	CbGeAlD
Methotrexate—GGH—kidney—malaria	0.000702	0.0119	CbGeAlD
Methotrexate—ABCC11—liver—malaria	0.00064	0.0109	CbGeAlD
Methotrexate—SLCO4C1—kidney—malaria	0.000622	0.0106	CbGeAlD
Methotrexate—SLC46A1—digestive system—malaria	0.000605	0.0103	CbGeAlD
Methotrexate—ABCC4—blood plasma—malaria	0.000604	0.0103	CbGeAlD
Methotrexate—ATIC—kidney—malaria	0.000597	0.0101	CbGeAlD
Methotrexate—GGH—digestive system—malaria	0.000595	0.0101	CbGeAlD
Methotrexate—SLC19A1—liver—malaria	0.000585	0.00994	CbGeAlD
Methotrexate—GGH—blood—malaria	0.000567	0.00964	CbGeAlD
Methotrexate—GGH—bone marrow—malaria	0.000549	0.00932	CbGeAlD
Methotrexate—MTHFR—hematopoietic system—malaria	0.000541	0.00919	CbGeAlD
Methotrexate—FOLR1—brain—malaria	0.00053	0.009	CbGeAlD
Methotrexate—FPGS—digestive system—malaria	0.000523	0.00889	CbGeAlD
Methotrexate—DHFR—saliva-secreting gland—malaria	0.000512	0.0087	CbGeAlD
Methotrexate—ATIC—digestive system—malaria	0.000506	0.0086	CbGeAlD
Methotrexate—SLCO4C1—blood—malaria	0.000503	0.00855	CbGeAlD
Methotrexate—FPGS—blood—malaria	0.000499	0.00847	CbGeAlD
Methotrexate—SLCO1C1—kidney—malaria	0.000496	0.00843	CbGeAlD
Methotrexate—TYMS—hematopoietic system—malaria	0.000494	0.00839	CbGeAlD
Methotrexate—PGD—saliva-secreting gland—malaria	0.000492	0.00837	CbGeAlD
Methotrexate—DHFR—hematopoietic system—malaria	0.000489	0.0083	CbGeAlD
Methotrexate—SLCO4C1—bone marrow—malaria	0.000487	0.00827	CbGeAlD
Methotrexate—ATIC—blood—malaria	0.000482	0.00819	CbGeAlD
Methotrexate—SLC22A11—kidney—malaria	0.000482	0.00819	CbGeAlD
Methotrexate—SLC22A7—kidney—malaria	0.00047	0.00799	CbGeAlD
Methotrexate—PGD—hematopoietic system—malaria	0.00047	0.00798	CbGeAlD
Methotrexate—SLC19A1—brain—malaria	0.000464	0.00789	CbGeAlD
Methotrexate—SLC46A1—liver—malaria	0.000451	0.00766	CbGeAlD
Methotrexate—GGH—liver—malaria	0.000443	0.00754	CbGeAlD
Methotrexate—SLC16A1—hematopoietic system—malaria	0.000439	0.00745	CbGeAlD
Methotrexate—SLCO3A1—kidney—malaria	0.000436	0.00741	CbGeAlD
Methotrexate—SLCO1B1—hematopoietic system—malaria	0.000427	0.00725	CbGeAlD
Methotrexate—ABCC10—saliva-secreting gland—malaria	0.000422	0.00717	CbGeAlD
Methotrexate—SLC22A11—digestive system—malaria	0.000409	0.00694	CbGeAlD
Methotrexate—ABCC3—hematopoietic system—malaria	0.000405	0.00688	CbGeAlD
Methotrexate—ABCC10—hematopoietic system—malaria	0.000403	0.00685	CbGeAlD
Methotrexate—DHFR—kidney—malaria	0.000401	0.00681	CbGeAlD
Methotrexate—SLC22A7—digestive system—malaria	0.000399	0.00678	CbGeAlD
Methotrexate—SLCO4C1—liver—malaria	0.000393	0.00668	CbGeAlD
Methotrexate—FPGS—liver—malaria	0.00039	0.00662	CbGeAlD
Methotrexate—PGD—kidney—malaria	0.000385	0.00654	CbGeAlD
Methotrexate—SLCO1B3—liver—malaria	0.000382	0.00649	CbGeAlD
Methotrexate—ATIC—liver—malaria	0.000377	0.00641	CbGeAlD
Methotrexate—MTHFR—digestive system—malaria	0.000376	0.00639	CbGeAlD
Methotrexate—SLC16A1—kidney—malaria	0.00036	0.00611	CbGeAlD
Methotrexate—MTHFR—blood—malaria	0.000358	0.00609	CbGeAlD
Methotrexate—SLC46A1—brain—malaria	0.000358	0.00608	CbGeAlD
Methotrexate—SLCO3A1—blood—malaria	0.000353	0.00599	CbGeAlD
Methotrexate—GGH—brain—malaria	0.000352	0.00598	CbGeAlD
Methotrexate—SLCO1B1—kidney—malaria	0.00035	0.00594	CbGeAlD
Methotrexate—SLCO1A2—hematopoietic system—malaria	0.000347	0.0059	CbGeAlD
Methotrexate—TYMS—digestive system—malaria	0.000343	0.00583	CbGeAlD
Methotrexate—DHFR—digestive system—malaria	0.00034	0.00577	CbGeAlD
Methotrexate—AOX1—kidney—malaria	0.000339	0.00576	CbGeAlD
Methotrexate—ABCC4—hematopoietic system—malaria	0.000334	0.00568	CbGeAlD
Methotrexate—ABCC3—kidney—malaria	0.000332	0.00564	CbGeAlD
Methotrexate—SLC22A8—hematopoietic system—malaria	0.000332	0.00563	CbGeAlD
Methotrexate—ABCC10—kidney—malaria	0.00033	0.00561	CbGeAlD
Methotrexate—TYMS—blood—malaria	0.000327	0.00556	CbGeAlD
Methotrexate—PGD—digestive system—malaria	0.000327	0.00555	CbGeAlD
Methotrexate—DHFR—blood—malaria	0.000324	0.0055	CbGeAlD
Methotrexate—TYMS—bone marrow—malaria	0.000316	0.00538	CbGeAlD
Methotrexate—DHFR—bone marrow—malaria	0.000313	0.00532	CbGeAlD
Methotrexate—PGD—blood—malaria	0.000311	0.00529	CbGeAlD
Methotrexate—FPGS—brain—malaria	0.000309	0.00526	CbGeAlD
Methotrexate—SLC16A1—digestive system—malaria	0.000305	0.00518	CbGeAlD
Methotrexate—SLC22A11—liver—malaria	0.000304	0.00517	CbGeAlD
Methotrexate—PGD—bone marrow—malaria	0.000301	0.00512	CbGeAlD
Methotrexate—ATIC—brain—malaria	0.000299	0.00508	CbGeAlD
Methotrexate—SLC22A7—liver—malaria	0.000297	0.00505	CbGeAlD
Methotrexate—SLCO1B1—digestive system—malaria	0.000297	0.00504	CbGeAlD
Methotrexate—AOX1—digestive system—malaria	0.000288	0.00489	CbGeAlD
Methotrexate—SLCO1A2—kidney—malaria	0.000285	0.00484	CbGeAlD
Methotrexate—SLCO1B1—blood—malaria	0.000283	0.0048	CbGeAlD
Methotrexate—ABCC3—digestive system—malaria	0.000282	0.00478	CbGeAlD
Methotrexate—MTHFR—liver—malaria	0.00028	0.00476	CbGeAlD
Methotrexate—ABCC10—digestive system—malaria	0.00028	0.00476	CbGeAlD
Methotrexate—SLCO3A1—liver—malaria	0.000276	0.00469	CbGeAlD
Methotrexate—ABCC4—kidney—malaria	0.000274	0.00465	CbGeAlD
Methotrexate—SLC22A8—kidney—malaria	0.000272	0.00462	CbGeAlD
Methotrexate—ABCC3—blood—malaria	0.000268	0.00456	CbGeAlD
Methotrexate—ABCC10—blood—malaria	0.000267	0.00454	CbGeAlD
Methotrexate—ABCC2—kidney—malaria	0.000265	0.00451	CbGeAlD
Methotrexate—ABCC10—bone marrow—malaria	0.000258	0.00439	CbGeAlD
Methotrexate—TYMS—liver—malaria	0.000256	0.00435	CbGeAlD
Methotrexate—DHFR—liver—malaria	0.000253	0.0043	CbGeAlD
Methotrexate—SLCO1C1—brain—malaria	0.000249	0.00423	CbGeAlD
Methotrexate—ABCG2—saliva-secreting gland—malaria	0.000247	0.0042	CbGeAlD
Methotrexate—PGD—liver—malaria	0.000243	0.00414	CbGeAlD
Methotrexate—SLCO1A2—digestive system—malaria	0.000241	0.0041	CbGeAlD
Methotrexate—SLC22A7—brain—malaria	0.000236	0.00401	CbGeAlD
Methotrexate—ABCC4—digestive system—malaria	0.000232	0.00395	CbGeAlD
Methotrexate—SLC22A6—brain—malaria	0.000228	0.00387	CbGeAlD
Methotrexate—SLC16A1—liver—malaria	0.000227	0.00386	CbGeAlD
Methotrexate—ABCC2—digestive system—malaria	0.000225	0.00382	CbGeAlD
Methotrexate—MTHFR—brain—malaria	0.000222	0.00378	CbGeAlD
Methotrexate—ABCC4—blood—malaria	0.000221	0.00376	CbGeAlD
Methotrexate—SLCO1B1—liver—malaria	0.000221	0.00376	CbGeAlD
Methotrexate—SLC22A8—blood—malaria	0.00022	0.00373	CbGeAlD
Methotrexate—SLCO3A1—brain—malaria	0.000219	0.00372	CbGeAlD
Methotrexate—AOX1—liver—malaria	0.000214	0.00364	CbGeAlD
Methotrexate—ABCC2—blood—malaria	0.000214	0.00364	CbGeAlD
Methotrexate—ABCC4—bone marrow—malaria	0.000214	0.00364	CbGeAlD
Methotrexate—ABCB1—blood plasma—malaria	0.00021	0.00357	CbGeAlD
Methotrexate—ABCC3—liver—malaria	0.00021	0.00356	CbGeAlD
Methotrexate—ABCC10—liver—malaria	0.000209	0.00355	CbGeAlD
Methotrexate—TYMS—brain—malaria	0.000203	0.00345	CbGeAlD
Methotrexate—DHFR—brain—malaria	0.000201	0.00341	CbGeAlD
Methotrexate—PGD—brain—malaria	0.000193	0.00328	CbGeAlD
Methotrexate—ABCC1—blood—malaria	0.000189	0.00321	CbGeAlD
Methotrexate—SLC16A1—brain—malaria	0.00018	0.00306	CbGeAlD
Methotrexate—SLCO1A2—liver—malaria	0.00018	0.00306	CbGeAlD
Methotrexate—ALB—liver—malaria	0.000179	0.00304	CbGeAlD
Methotrexate—ABCC4—liver—malaria	0.000173	0.00294	CbGeAlD
Methotrexate—AOX1—brain—malaria	0.00017	0.00289	CbGeAlD
Methotrexate—ABCC2—liver—malaria	0.000168	0.00285	CbGeAlD
Methotrexate—ABCC3—brain—malaria	0.000166	0.00283	CbGeAlD
Methotrexate—ABCC10—brain—malaria	0.000166	0.00281	CbGeAlD
Methotrexate—ABCG2—blood—malaria	0.000156	0.00266	CbGeAlD
Methotrexate—ABCG2—bone marrow—malaria	0.000151	0.00257	CbGeAlD
Methotrexate—Thrombocytopenia—Sulfadiazine—malaria	0.00015	0.00152	CcSEcCtD
Methotrexate—Hepatobiliary disease—Pentoxifylline—malaria	0.000149	0.00152	CcSEcCtD
Methotrexate—Epistaxis—Pentoxifylline—malaria	0.000149	0.00152	CcSEcCtD
Methotrexate—Erythema multiforme—Quinidine—malaria	0.000149	0.00151	CcSEcCtD
Methotrexate—Erythema multiforme—Quinine—malaria	0.000149	0.00151	CcSEcCtD
Methotrexate—ABCC1—liver—malaria	0.000148	0.00251	CbGeAlD
Methotrexate—Agranulocytosis—Quinidine barbiturate—malaria	0.000147	0.0015	CcSEcCtD
Methotrexate—Eye disorder—Quinine—malaria	0.000147	0.0015	CcSEcCtD
Methotrexate—Eye disorder—Quinidine—malaria	0.000147	0.0015	CcSEcCtD
Methotrexate—Tinnitus—Quinine—malaria	0.000147	0.00149	CcSEcCtD
Methotrexate—Tinnitus—Quinidine—malaria	0.000147	0.00149	CcSEcCtD
Methotrexate—Vomiting—Proguanil—malaria	0.000146	0.00149	CcSEcCtD
Methotrexate—Cardiac disorder—Quinine—malaria	0.000146	0.00149	CcSEcCtD
Methotrexate—Cardiac disorder—Quinidine—malaria	0.000146	0.00149	CcSEcCtD
Methotrexate—Anorexia—Sulfadiazine—malaria	0.000146	0.00148	CcSEcCtD
Methotrexate—Rash—Proguanil—malaria	0.000145	0.00148	CcSEcCtD
Methotrexate—Dermatitis—Proguanil—malaria	0.000145	0.00148	CcSEcCtD
Methotrexate—Headache—Proguanil—malaria	0.000144	0.00147	CcSEcCtD
Methotrexate—Erythema—Dapsone—malaria	0.000144	0.00147	CcSEcCtD
Methotrexate—SLCO1A2—brain—malaria	0.000143	0.00243	CbGeAlD
Methotrexate—Haemoglobin—Quinidine barbiturate—malaria	0.000143	0.00145	CcSEcCtD
Methotrexate—Haemoglobin—Pentoxifylline—malaria	0.000142	0.00145	CcSEcCtD
Methotrexate—Immune system disorder—Quinine—malaria	0.000142	0.00145	CcSEcCtD
Methotrexate—Immune system disorder—Quinidine—malaria	0.000142	0.00145	CcSEcCtD
Methotrexate—ALB—brain—malaria	0.000142	0.00241	CbGeAlD
Methotrexate—Hepatitis—Quinidine barbiturate—malaria	0.000142	0.00144	CcSEcCtD
Methotrexate—Haemorrhage—Quinidine barbiturate—malaria	0.000142	0.00144	CcSEcCtD
Methotrexate—Mediastinal disorder—Quinine—malaria	0.000142	0.00144	CcSEcCtD
Methotrexate—Mediastinal disorder—Quinidine—malaria	0.000142	0.00144	CcSEcCtD
Methotrexate—Hepatitis—Pentoxifylline—malaria	0.000142	0.00144	CcSEcCtD
Methotrexate—Haemorrhage—Pentoxifylline—malaria	0.000142	0.00144	CcSEcCtD
Methotrexate—Chills—Quinidine—malaria	0.000141	0.00144	CcSEcCtD
Methotrexate—Chills—Quinine—malaria	0.000141	0.00144	CcSEcCtD
Methotrexate—Urinary tract disorder—Quinidine barbiturate—malaria	0.00014	0.00143	CcSEcCtD
Methotrexate—Erythema—Clindamycin—malaria	0.000139	0.00142	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000139	0.00142	CcSEcCtD
Methotrexate—Urethral disorder—Quinidine barbiturate—malaria	0.000139	0.00142	CcSEcCtD
Methotrexate—Insomnia—Sulfadiazine—malaria	0.000138	0.00141	CcSEcCtD
Methotrexate—Mental disorder—Quinidine—malaria	0.000138	0.0014	CcSEcCtD
Methotrexate—Mental disorder—Quinine—malaria	0.000138	0.0014	CcSEcCtD
Methotrexate—ABCC4—brain—malaria	0.000137	0.00233	CbGeAlD
Methotrexate—Erythema—Quinidine—malaria	0.000137	0.00139	CcSEcCtD
Methotrexate—Erythema—Quinine—malaria	0.000137	0.00139	CcSEcCtD
Methotrexate—Malnutrition—Quinidine—malaria	0.000137	0.00139	CcSEcCtD
Methotrexate—Malnutrition—Quinine—malaria	0.000137	0.00139	CcSEcCtD
Methotrexate—Nausea—Proguanil—malaria	0.000137	0.00139	CcSEcCtD
Methotrexate—Visual impairment—Quinidine barbiturate—malaria	0.000137	0.00139	CcSEcCtD
Methotrexate—Dysgeusia—Clindamycin—malaria	0.000137	0.00139	CcSEcCtD
Methotrexate—SLC22A8—brain—malaria	0.000136	0.00232	CbGeAlD
Methotrexate—Vision blurred—Dapsone—malaria	0.000136	0.00138	CcSEcCtD
Methotrexate—Back pain—Clindamycin—malaria	0.000135	0.00137	CcSEcCtD
Methotrexate—Erythema multiforme—Quinidine barbiturate—malaria	0.000134	0.00137	CcSEcCtD
Methotrexate—Decreased appetite—Sulfadiazine—malaria	0.000133	0.00135	CcSEcCtD
Methotrexate—Eye disorder—Quinidine barbiturate—malaria	0.000133	0.00135	CcSEcCtD
Methotrexate—Tinnitus—Quinidine barbiturate—malaria	0.000132	0.00135	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Sulfadiazine—malaria	0.000132	0.00134	CcSEcCtD
Methotrexate—Cardiac disorder—Quinidine barbiturate—malaria	0.000132	0.00134	CcSEcCtD
Methotrexate—Vertigo—Dapsone—malaria	0.00013	0.00132	CcSEcCtD
Methotrexate—Vision blurred—Quinine—malaria	0.000129	0.00131	CcSEcCtD
Methotrexate—Vision blurred—Quinidine—malaria	0.000129	0.00131	CcSEcCtD
Methotrexate—Anaemia—Clindamycin—malaria	0.000129	0.00131	CcSEcCtD
Methotrexate—Immune system disorder—Quinidine barbiturate—malaria	0.000128	0.0013	CcSEcCtD
Methotrexate—Immune system disorder—Pentoxifylline—malaria	0.000128	0.0013	CcSEcCtD
Methotrexate—Mediastinal disorder—Quinidine barbiturate—malaria	0.000128	0.0013	CcSEcCtD
Methotrexate—Chills—Quinidine barbiturate—malaria	0.000127	0.0013	CcSEcCtD
Methotrexate—Cough—Dapsone—malaria	0.000126	0.00128	CcSEcCtD
Methotrexate—Vertigo—Clindamycin—malaria	0.000125	0.00128	CcSEcCtD
Methotrexate—Gastrointestinal pain—Sulfadiazine—malaria	0.000125	0.00127	CcSEcCtD
Methotrexate—Leukopenia—Clindamycin—malaria	0.000125	0.00127	CcSEcCtD
Methotrexate—Mental disorder—Quinidine barbiturate—malaria	0.000124	0.00127	CcSEcCtD
Methotrexate—Malnutrition—Quinidine barbiturate—malaria	0.000123	0.00126	CcSEcCtD
Methotrexate—Erythema—Quinidine barbiturate—malaria	0.000123	0.00126	CcSEcCtD
Methotrexate—Erythema—Pentoxifylline—malaria	0.000123	0.00126	CcSEcCtD
Methotrexate—Vertigo—Quinine—malaria	0.000123	0.00125	CcSEcCtD
Methotrexate—Vertigo—Quinidine—malaria	0.000123	0.00125	CcSEcCtD
Methotrexate—Leukopenia—Quinine—malaria	0.000122	0.00125	CcSEcCtD
Methotrexate—Leukopenia—Quinidine—malaria	0.000122	0.00125	CcSEcCtD
Methotrexate—ABCG2—liver—malaria	0.000122	0.00208	CbGeAlD
Methotrexate—Urticaria—Sulfadiazine—malaria	0.000121	0.00124	CcSEcCtD
Methotrexate—Body temperature increased—Sulfadiazine—malaria	0.000121	0.00123	CcSEcCtD
Methotrexate—Abdominal pain—Sulfadiazine—malaria	0.000121	0.00123	CcSEcCtD
Methotrexate—Dysgeusia—Pentoxifylline—malaria	0.000121	0.00123	CcSEcCtD
Methotrexate—Back pain—Pentoxifylline—malaria	0.000119	0.00121	CcSEcCtD
Methotrexate—Convulsion—Quinidine—malaria	0.000119	0.00121	CcSEcCtD
Methotrexate—Convulsion—Quinine—malaria	0.000119	0.00121	CcSEcCtD
Methotrexate—Discomfort—Clindamycin—malaria	0.000117	0.00119	CcSEcCtD
Methotrexate—ABCC1—brain—malaria	0.000117	0.00199	CbGeAlD
Methotrexate—Chest pain—Quinine—malaria	0.000116	0.00119	CcSEcCtD
Methotrexate—Myalgia—Quinine—malaria	0.000116	0.00119	CcSEcCtD
Methotrexate—Myalgia—Quinidine—malaria	0.000116	0.00119	CcSEcCtD
Methotrexate—Chest pain—Quinidine—malaria	0.000116	0.00119	CcSEcCtD
Methotrexate—Vision blurred—Quinidine barbiturate—malaria	0.000116	0.00119	CcSEcCtD
Methotrexate—ABCB1—hematopoietic system—malaria	0.000116	0.00198	CbGeAlD
Methotrexate—Vision blurred—Pentoxifylline—malaria	0.000116	0.00118	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000116	0.00118	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000116	0.00118	CcSEcCtD
Methotrexate—Ill-defined disorder—Pentoxifylline—malaria	0.000114	0.00116	CcSEcCtD
Methotrexate—Anaemia—Pentoxifylline—malaria	0.000114	0.00116	CcSEcCtD
Methotrexate—Anaphylactic shock—Clindamycin—malaria	0.000114	0.00116	CcSEcCtD
Methotrexate—Hypersensitivity—Sulfadiazine—malaria	0.000113	0.00115	CcSEcCtD
Methotrexate—Confusional state—Quinine—malaria	0.000113	0.00115	CcSEcCtD
Methotrexate—Confusional state—Quinidine—malaria	0.000113	0.00115	CcSEcCtD
Methotrexate—Thrombocytopenia—Clindamycin—malaria	0.000111	0.00113	CcSEcCtD
Methotrexate—Malaise—Pentoxifylline—malaria	0.000111	0.00113	CcSEcCtD
Methotrexate—Vertigo—Quinidine barbiturate—malaria	0.000111	0.00113	CcSEcCtD
Methotrexate—Leukopenia—Quinidine barbiturate—malaria	0.000111	0.00113	CcSEcCtD
Methotrexate—Leukopenia—Pentoxifylline—malaria	0.00011	0.00112	CcSEcCtD
Methotrexate—Nervous system disorder—Quinidine—malaria	0.00011	0.00112	CcSEcCtD
Methotrexate—Nervous system disorder—Quinine—malaria	0.00011	0.00112	CcSEcCtD
Methotrexate—Thrombocytopenia—Quinine—malaria	0.000109	0.00111	CcSEcCtD
Methotrexate—Thrombocytopenia—Quinidine—malaria	0.000109	0.00111	CcSEcCtD
Methotrexate—Skin disorder—Quinine—malaria	0.000108	0.0011	CcSEcCtD
Methotrexate—Skin disorder—Quinidine—malaria	0.000108	0.0011	CcSEcCtD
Methotrexate—Pruritus—Sulfadiazine—malaria	0.000108	0.0011	CcSEcCtD
Methotrexate—Hyperhidrosis—Quinidine—malaria	0.000108	0.0011	CcSEcCtD
Methotrexate—Hyperhidrosis—Quinine—malaria	0.000108	0.0011	CcSEcCtD
Methotrexate—Convulsion—Quinidine barbiturate—malaria	0.000107	0.00109	CcSEcCtD
Methotrexate—Convulsion—Pentoxifylline—malaria	0.000107	0.00109	CcSEcCtD
Methotrexate—Anorexia—Quinine—malaria	0.000106	0.00108	CcSEcCtD
Methotrexate—Anorexia—Quinidine—malaria	0.000106	0.00108	CcSEcCtD
Methotrexate—Insomnia—Dapsone—malaria	0.000106	0.00108	CcSEcCtD
Methotrexate—Hypotension—Clindamycin—malaria	0.000106	0.00108	CcSEcCtD
Methotrexate—Arthralgia—Quinidine barbiturate—malaria	0.000105	0.00107	CcSEcCtD
Methotrexate—Chest pain—Quinidine barbiturate—malaria	0.000105	0.00107	CcSEcCtD
Methotrexate—Myalgia—Quinidine barbiturate—malaria	0.000105	0.00107	CcSEcCtD
Methotrexate—Chest pain—Pentoxifylline—malaria	0.000105	0.00107	CcSEcCtD
Methotrexate—Myalgia—Pentoxifylline—malaria	0.000105	0.00107	CcSEcCtD
Methotrexate—Diarrhoea—Sulfadiazine—malaria	0.000105	0.00107	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000104	0.00106	CcSEcCtD
Methotrexate—Hypotension—Quinine—malaria	0.000104	0.00106	CcSEcCtD
Methotrexate—Hypotension—Quinidine—malaria	0.000104	0.00106	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000104	0.00106	CcSEcCtD
Methotrexate—Discomfort—Pentoxifylline—malaria	0.000104	0.00106	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Quinidine—malaria	0.000102	0.00104	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Quinine—malaria	0.000102	0.00104	CcSEcCtD
Methotrexate—Confusional state—Quinidine barbiturate—malaria	0.000102	0.00103	CcSEcCtD
Methotrexate—Dyspnoea—Clindamycin—malaria	0.000101	0.00103	CcSEcCtD
Methotrexate—Confusional state—Pentoxifylline—malaria	0.000101	0.00103	CcSEcCtD
Methotrexate—Anaphylactic shock—Pentoxifylline—malaria	0.000101	0.00102	CcSEcCtD
Methotrexate—Dyspepsia—Clindamycin—malaria	0.0001	0.00102	CcSEcCtD
Methotrexate—Infection—Pentoxifylline—malaria	9.99e-05	0.00102	CcSEcCtD
Methotrexate—Dyspnoea—Quinine—malaria	9.96e-05	0.00101	CcSEcCtD
Methotrexate—Dyspnoea—Quinidine—malaria	9.96e-05	0.00101	CcSEcCtD
Methotrexate—Nervous system disorder—Quinidine barbiturate—malaria	9.88e-05	0.00101	CcSEcCtD
Methotrexate—Thrombocytopenia—Quinidine barbiturate—malaria	9.87e-05	0.001	CcSEcCtD
Methotrexate—Thrombocytopenia—Pentoxifylline—malaria	9.85e-05	0.001	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Clindamycin—malaria	9.83e-05	0.001	CcSEcCtD
Methotrexate—Fatigue—Clindamycin—malaria	9.81e-05	0.000999	CcSEcCtD
Methotrexate—Skin disorder—Quinidine barbiturate—malaria	9.79e-05	0.000997	CcSEcCtD
Methotrexate—Skin disorder—Pentoxifylline—malaria	9.77e-05	0.000995	CcSEcCtD
Methotrexate—Hyperhidrosis—Quinidine barbiturate—malaria	9.74e-05	0.000992	CcSEcCtD
Methotrexate—Pain—Clindamycin—malaria	9.73e-05	0.000991	CcSEcCtD
Methotrexate—Hyperhidrosis—Pentoxifylline—malaria	9.73e-05	0.00099	CcSEcCtD
Methotrexate—Vomiting—Sulfadiazine—malaria	9.72e-05	0.00099	CcSEcCtD
Methotrexate—Decreased appetite—Quinidine—malaria	9.71e-05	0.000989	CcSEcCtD
Methotrexate—Decreased appetite—Quinine—malaria	9.71e-05	0.000989	CcSEcCtD
Methotrexate—ABCG2—brain—malaria	9.7e-05	0.00165	CbGeAlD
Methotrexate—Gastrointestinal disorder—Quinine—malaria	9.64e-05	0.000982	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Quinidine—malaria	9.64e-05	0.000982	CcSEcCtD
Methotrexate—Rash—Sulfadiazine—malaria	9.64e-05	0.000981	CcSEcCtD
Methotrexate—Dermatitis—Sulfadiazine—malaria	9.63e-05	0.000981	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dapsone—malaria	9.62e-05	0.00098	CcSEcCtD
Methotrexate—Anorexia—Quinidine barbiturate—malaria	9.61e-05	0.000978	CcSEcCtD
Methotrexate—Anorexia—Pentoxifylline—malaria	9.59e-05	0.000977	CcSEcCtD
Methotrexate—Headache—Sulfadiazine—malaria	9.58e-05	0.000975	CcSEcCtD
Methotrexate—ABCB1—kidney—malaria	9.54e-05	0.00162	CbGeAlD
Methotrexate—Hypotension—Quinidine barbiturate—malaria	9.42e-05	0.000959	CcSEcCtD
Methotrexate—Hypotension—Pentoxifylline—malaria	9.4e-05	0.000957	CcSEcCtD
Methotrexate—Gastrointestinal pain—Clindamycin—malaria	9.31e-05	0.000948	CcSEcCtD
Methotrexate—Body temperature increased—Dapsone—malaria	9.3e-05	0.000947	CcSEcCtD
Methotrexate—Abdominal pain—Dapsone—malaria	9.3e-05	0.000947	CcSEcCtD
Methotrexate—Feeling abnormal—Quinidine—malaria	9.2e-05	0.000937	CcSEcCtD
Methotrexate—Feeling abnormal—Quinine—malaria	9.2e-05	0.000937	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Quinidine barbiturate—malaria	9.18e-05	0.000935	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Pentoxifylline—malaria	9.17e-05	0.000933	CcSEcCtD
Methotrexate—Gastrointestinal pain—Quinine—malaria	9.13e-05	0.00093	CcSEcCtD
Methotrexate—Gastrointestinal pain—Quinidine—malaria	9.13e-05	0.00093	CcSEcCtD
Methotrexate—Insomnia—Pentoxifylline—malaria	9.1e-05	0.000927	CcSEcCtD
Methotrexate—Nausea—Sulfadiazine—malaria	9.08e-05	0.000925	CcSEcCtD
Methotrexate—Urticaria—Clindamycin—malaria	9.04e-05	0.000921	CcSEcCtD
Methotrexate—Body temperature increased—Clindamycin—malaria	9e-05	0.000916	CcSEcCtD
Methotrexate—Abdominal pain—Clindamycin—malaria	9e-05	0.000916	CcSEcCtD
Methotrexate—Dyspnoea—Quinidine barbiturate—malaria	8.99e-05	0.000915	CcSEcCtD
Methotrexate—Dyspnoea—Pentoxifylline—malaria	8.97e-05	0.000913	CcSEcCtD
Methotrexate—Somnolence—Quinidine barbiturate—malaria	8.96e-05	0.000912	CcSEcCtD
Methotrexate—Somnolence—Pentoxifylline—malaria	8.94e-05	0.000911	CcSEcCtD
Methotrexate—Urticaria—Quinidine—malaria	8.87e-05	0.000903	CcSEcCtD
Methotrexate—Urticaria—Quinine—malaria	8.87e-05	0.000903	CcSEcCtD
Methotrexate—Dyspepsia—Pentoxifylline—malaria	8.86e-05	0.000902	CcSEcCtD
Methotrexate—Abdominal pain—Quinidine—malaria	8.83e-05	0.000899	CcSEcCtD
Methotrexate—Body temperature increased—Quinidine—malaria	8.83e-05	0.000899	CcSEcCtD
Methotrexate—Abdominal pain—Quinine—malaria	8.83e-05	0.000899	CcSEcCtD
Methotrexate—Body temperature increased—Quinine—malaria	8.83e-05	0.000899	CcSEcCtD
Methotrexate—Decreased appetite—Quinidine barbiturate—malaria	8.76e-05	0.000892	CcSEcCtD
Methotrexate—Decreased appetite—Pentoxifylline—malaria	8.75e-05	0.000891	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Quinidine barbiturate—malaria	8.7e-05	0.000886	CcSEcCtD
Methotrexate—Pain—Quinidine barbiturate—malaria	8.62e-05	0.000878	CcSEcCtD
Methotrexate—Hypersensitivity—Clindamycin—malaria	8.39e-05	0.000854	CcSEcCtD
Methotrexate—Feeling abnormal—Quinidine barbiturate—malaria	8.3e-05	0.000846	CcSEcCtD
Methotrexate—Feeling abnormal—Pentoxifylline—malaria	8.29e-05	0.000844	CcSEcCtD
Methotrexate—Gastrointestinal pain—Quinidine barbiturate—malaria	8.24e-05	0.000839	CcSEcCtD
Methotrexate—Hypersensitivity—Quinidine—malaria	8.23e-05	0.000838	CcSEcCtD
Methotrexate—Hypersensitivity—Quinine—malaria	8.23e-05	0.000838	CcSEcCtD
Methotrexate—Gastrointestinal pain—Pentoxifylline—malaria	8.23e-05	0.000838	CcSEcCtD
Methotrexate—Asthenia—Clindamycin—malaria	8.17e-05	0.000832	CcSEcCtD
Methotrexate—ABCB1—digestive system—malaria	8.09e-05	0.00137	CbGeAlD
Methotrexate—Pruritus—Clindamycin—malaria	8.05e-05	0.00082	CcSEcCtD
Methotrexate—Asthenia—Quinine—malaria	8.01e-05	0.000816	CcSEcCtD
Methotrexate—Asthenia—Quinidine—malaria	8.01e-05	0.000816	CcSEcCtD
Methotrexate—Urticaria—Quinidine barbiturate—malaria	8.01e-05	0.000815	CcSEcCtD
Methotrexate—Urticaria—Pentoxifylline—malaria	7.99e-05	0.000814	CcSEcCtD
Methotrexate—Abdominal pain—Quinidine barbiturate—malaria	7.97e-05	0.000811	CcSEcCtD
Methotrexate—Body temperature increased—Quinidine barbiturate—malaria	7.97e-05	0.000811	CcSEcCtD
Methotrexate—Body temperature increased—Pentoxifylline—malaria	7.95e-05	0.00081	CcSEcCtD
Methotrexate—Abdominal pain—Pentoxifylline—malaria	7.95e-05	0.00081	CcSEcCtD
Methotrexate—Pruritus—Quinine—malaria	7.9e-05	0.000805	CcSEcCtD
Methotrexate—Pruritus—Quinidine—malaria	7.9e-05	0.000805	CcSEcCtD
Methotrexate—Diarrhoea—Clindamycin—malaria	7.79e-05	0.000793	CcSEcCtD
Methotrexate—ABCB1—blood—malaria	7.71e-05	0.00131	CbGeAlD
Methotrexate—Diarrhoea—Quinine—malaria	7.64e-05	0.000778	CcSEcCtD
Methotrexate—Diarrhoea—Quinidine—malaria	7.64e-05	0.000778	CcSEcCtD
Methotrexate—Dizziness—Clindamycin—malaria	7.53e-05	0.000767	CcSEcCtD
Methotrexate—Vomiting—Dapsone—malaria	7.48e-05	0.000762	CcSEcCtD
Methotrexate—ABCB1—bone marrow—malaria	7.46e-05	0.00127	CbGeAlD
Methotrexate—Hypersensitivity—Quinidine barbiturate—malaria	7.43e-05	0.000756	CcSEcCtD
Methotrexate—Hypersensitivity—Pentoxifylline—malaria	7.41e-05	0.000755	CcSEcCtD
Methotrexate—Dizziness—Quinidine—malaria	7.38e-05	0.000752	CcSEcCtD
Methotrexate—Dizziness—Quinine—malaria	7.38e-05	0.000752	CcSEcCtD
Methotrexate—Headache—Dapsone—malaria	7.37e-05	0.000751	CcSEcCtD
Methotrexate—Vomiting—Clindamycin—malaria	7.24e-05	0.000737	CcSEcCtD
Methotrexate—Asthenia—Quinidine barbiturate—malaria	7.23e-05	0.000736	CcSEcCtD
Methotrexate—Asthenia—Pentoxifylline—malaria	7.22e-05	0.000735	CcSEcCtD
Methotrexate—Rash—Clindamycin—malaria	7.18e-05	0.000731	CcSEcCtD
Methotrexate—Dermatitis—Clindamycin—malaria	7.17e-05	0.00073	CcSEcCtD
Methotrexate—Headache—Clindamycin—malaria	7.13e-05	0.000726	CcSEcCtD
Methotrexate—Pruritus—Quinidine barbiturate—malaria	7.13e-05	0.000726	CcSEcCtD
Methotrexate—Pruritus—Pentoxifylline—malaria	7.12e-05	0.000725	CcSEcCtD
Methotrexate—Vomiting—Quinine—malaria	7.1e-05	0.000723	CcSEcCtD
Methotrexate—Vomiting—Quinidine—malaria	7.1e-05	0.000723	CcSEcCtD
Methotrexate—Rash—Quinidine—malaria	7.04e-05	0.000717	CcSEcCtD
Methotrexate—Rash—Quinine—malaria	7.04e-05	0.000717	CcSEcCtD
Methotrexate—Dermatitis—Quinine—malaria	7.03e-05	0.000716	CcSEcCtD
Methotrexate—Dermatitis—Quinidine—malaria	7.03e-05	0.000716	CcSEcCtD
Methotrexate—Headache—Quinidine—malaria	7e-05	0.000712	CcSEcCtD
Methotrexate—Headache—Quinine—malaria	7e-05	0.000712	CcSEcCtD
Methotrexate—Nausea—Dapsone—malaria	6.99e-05	0.000712	CcSEcCtD
Methotrexate—Diarrhoea—Quinidine barbiturate—malaria	6.9e-05	0.000702	CcSEcCtD
Methotrexate—Diarrhoea—Pentoxifylline—malaria	6.88e-05	0.000701	CcSEcCtD
Methotrexate—Nausea—Clindamycin—malaria	6.76e-05	0.000689	CcSEcCtD
Methotrexate—Dizziness—Quinidine barbiturate—malaria	6.66e-05	0.000679	CcSEcCtD
Methotrexate—Dizziness—Pentoxifylline—malaria	6.65e-05	0.000677	CcSEcCtD
Methotrexate—Nausea—Quinidine—malaria	6.63e-05	0.000675	CcSEcCtD
Methotrexate—Nausea—Quinine—malaria	6.63e-05	0.000675	CcSEcCtD
Methotrexate—Vomiting—Quinidine barbiturate—malaria	6.41e-05	0.000653	CcSEcCtD
Methotrexate—Vomiting—Pentoxifylline—malaria	6.4e-05	0.000651	CcSEcCtD
Methotrexate—Rash—Quinidine barbiturate—malaria	6.35e-05	0.000647	CcSEcCtD
Methotrexate—Dermatitis—Quinidine barbiturate—malaria	6.35e-05	0.000646	CcSEcCtD
Methotrexate—Rash—Pentoxifylline—malaria	6.34e-05	0.000646	CcSEcCtD
Methotrexate—Dermatitis—Pentoxifylline—malaria	6.34e-05	0.000645	CcSEcCtD
Methotrexate—Headache—Quinidine barbiturate—malaria	6.31e-05	0.000643	CcSEcCtD
Methotrexate—Headache—Pentoxifylline—malaria	6.3e-05	0.000642	CcSEcCtD
Methotrexate—ABCB1—liver—malaria	6.03e-05	0.00102	CbGeAlD
Methotrexate—Nausea—Quinidine barbiturate—malaria	5.99e-05	0.00061	CcSEcCtD
Methotrexate—Nausea—Pentoxifylline—malaria	5.98e-05	0.000609	CcSEcCtD
Methotrexate—ABCB1—brain—malaria	4.78e-05	0.000813	CbGeAlD
Methotrexate—ATIC—Metabolism—SCARB1—malaria	3.91e-05	0.000595	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—SCARB1—malaria	3.91e-05	0.000595	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SLC4A1—malaria	3.89e-05	0.000592	CbGpPWpGaD
Methotrexate—MTHFR—Selenium Micronutrient Network—IL6—malaria	3.8e-05	0.000578	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SLC4A1—malaria	3.8e-05	0.000578	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—NOS2—malaria	3.8e-05	0.000578	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—DHFR—malaria	3.75e-05	0.000571	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—DHODH—malaria	3.7e-05	0.000563	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—DHFR—malaria	3.68e-05	0.00056	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC4A1—malaria	3.67e-05	0.000559	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—DECR1—malaria	3.66e-05	0.000556	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—CRP—malaria	3.57e-05	0.000544	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—DECR1—malaria	3.57e-05	0.000543	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—DHODH—malaria	3.55e-05	0.00054	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PKLR—malaria	3.52e-05	0.000535	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SLC4A1—malaria	3.46e-05	0.000526	CbGpPWpGaD
Methotrexate—AOX1—Disease—PKLR—malaria	3.44e-05	0.000523	CbGpPWpGaD
Methotrexate—ALB—Platelet degranulation—CD36—malaria	3.4e-05	0.000517	CbGpPWpGaD
Methotrexate—PGD—Disease—DHFR—malaria	3.36e-05	0.000512	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—DHFR—malaria	3.35e-05	0.00051	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—CD36—malaria	3.33e-05	0.000507	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—HPGDS—malaria	3.32e-05	0.000505	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—HBB—malaria	3.31e-05	0.000503	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—ICAM1—malaria	3.29e-05	0.0005	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—DHODH—malaria	3.25e-05	0.000495	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—DECR1—malaria	3.25e-05	0.000494	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—CD36—malaria	3.24e-05	0.000493	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—HBB—malaria	3.23e-05	0.000491	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL10—malaria	3.23e-05	0.000491	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—CD40LG—malaria	3.23e-05	0.000491	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.2e-05	0.000487	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SLC4A1—malaria	3.15e-05	0.000479	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL4—malaria	3.14e-05	0.000478	CbGpPWpGaD
Methotrexate—MTHFR—Disease—G6PD—malaria	3.14e-05	0.000477	CbGpPWpGaD
Methotrexate—DHFR—Disease—PKLR—malaria	3.13e-05	0.000476	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—DHFR—malaria	3.08e-05	0.000469	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—IFNG—malaria	3.07e-05	0.000468	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—HLA-B—malaria	3.07e-05	0.000467	CbGpPWpGaD
Methotrexate—AOX1—Disease—G6PD—malaria	3.06e-05	0.000466	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—SCARB1—malaria	3.05e-05	0.000464	CbGpPWpGaD
Methotrexate—PGD—Metabolism—HPGDS—malaria	3.04e-05	0.000462	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SLC4A1—malaria	3.01e-05	0.000459	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—DECR1—malaria	2.96e-05	0.00045	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PKLR—malaria	2.95e-05	0.000448	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—HBB—malaria	2.94e-05	0.000447	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.94e-05	0.000447	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—DHODH—malaria	2.93e-05	0.000447	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—FAS—malaria	2.89e-05	0.00044	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—CD36—malaria	2.89e-05	0.000439	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.89e-05	0.000439	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PKLR—malaria	2.88e-05	0.000438	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	2.86e-05	0.000435	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—CRP—malaria	2.84e-05	0.000432	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—DECR1—malaria	2.83e-05	0.000431	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—NOS2—malaria	2.83e-05	0.000431	CbGpPWpGaD
Methotrexate—PGD—Metabolism—DHFR—malaria	2.82e-05	0.000429	CbGpPWpGaD
Methotrexate—PGD—Metabolism—SCARB1—malaria	2.79e-05	0.000424	CbGpPWpGaD
Methotrexate—DHFR—Disease—G6PD—malaria	2.79e-05	0.000424	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SLC4A1—malaria	2.77e-05	0.000421	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—IL1B—malaria	2.74e-05	0.000417	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—HBB—malaria	2.68e-05	0.000407	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.65e-05	0.000403	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—G6PD—malaria	2.63e-05	0.0004	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PKLR—malaria	2.62e-05	0.000398	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—ICAM1—malaria	2.61e-05	0.000397	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—DECR1—malaria	2.6e-05	0.000396	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	2.58e-05	0.000392	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—G6PD—malaria	2.57e-05	0.00039	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—HBB—malaria	2.56e-05	0.00039	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—DHODH—malaria	2.56e-05	0.000389	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.51e-05	0.000383	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IFNG—malaria	2.5e-05	0.00038	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SLC4A1—malaria	2.5e-05	0.00038	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—CD36—malaria	2.45e-05	0.000374	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—CD36—malaria	2.45e-05	0.000374	CbGpPWpGaD
Methotrexate—FPGS—Disease—NOS2—malaria	2.41e-05	0.000367	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PKLR—malaria	2.38e-05	0.000363	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—HBB—malaria	2.35e-05	0.000358	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—DECR1—malaria	2.35e-05	0.000357	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—G6PD—malaria	2.33e-05	0.000355	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.31e-05	0.000351	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—CD36—malaria	2.3e-05	0.000351	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—DHODH—malaria	2.3e-05	0.00035	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PKLR—malaria	2.28e-05	0.000348	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC4A1—malaria	2.27e-05	0.000345	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.26e-05	0.000344	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—DECR1—malaria	2.24e-05	0.000341	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL1B—malaria	2.23e-05	0.000339	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HBB—malaria	2.23e-05	0.000339	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL2—malaria	2.22e-05	0.000338	CbGpPWpGaD
Methotrexate—MTHFR—Disease—DHFR—malaria	2.22e-05	0.000338	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—DHODH—malaria	2.19e-05	0.000333	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SLC4A1—malaria	2.17e-05	0.000331	CbGpPWpGaD
Methotrexate—AOX1—Disease—DHFR—malaria	2.17e-05	0.00033	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.15e-05	0.000327	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—G6PD—malaria	2.13e-05	0.000323	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—HBB—malaria	2.12e-05	0.000323	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—CD4—malaria	2.1e-05	0.000319	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PKLR—malaria	2.1e-05	0.000319	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.08e-05	0.000316	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—DECR1—malaria	2.04e-05	0.000311	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—G6PD—malaria	2.04e-05	0.00031	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—DHODH—malaria	2.02e-05	0.000308	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—HPGDS—malaria	2e-05	0.000305	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—TNF—malaria	1.99e-05	0.000303	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	1.99e-05	0.000302	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IFNG—malaria	1.99e-05	0.000302	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.97e-05	0.0003	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.96e-05	0.000299	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—HPGDS—malaria	1.96e-05	0.000298	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SLC4A1—malaria	1.96e-05	0.000298	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—CD36—malaria	1.91e-05	0.000291	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IFNG—malaria	1.9e-05	0.000289	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NOS2—malaria	1.89e-05	0.000288	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PKLR—malaria	1.89e-05	0.000288	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NOS2—malaria	1.88e-05	0.000286	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—G6PD—malaria	1.87e-05	0.000284	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—IL2—malaria	1.87e-05	0.000284	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—DHFR—malaria	1.86e-05	0.000283	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SLC4A1—malaria	1.86e-05	0.000283	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—HBB—malaria	1.85e-05	0.000281	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—malaria	1.84e-05	0.000281	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SCARB1—malaria	1.84e-05	0.00028	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—DECR1—malaria	1.84e-05	0.00028	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—DHFR—malaria	1.81e-05	0.000276	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SCARB1—malaria	1.8e-05	0.000273	CbGpPWpGaD
Methotrexate—FPGS—Disease—CD4—malaria	1.79e-05	0.000272	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—HPGDS—malaria	1.78e-05	0.000271	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL1B—malaria	1.77e-05	0.00027	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PKLR—malaria	1.77e-05	0.000269	CbGpPWpGaD
Methotrexate—PGD—Metabolism—CD36—malaria	1.75e-05	0.000266	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—DECR1—malaria	1.75e-05	0.000266	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SLC4A1—malaria	1.72e-05	0.000262	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—CD36—malaria	1.72e-05	0.000261	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS2—malaria	1.72e-05	0.000261	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL1B—malaria	1.69e-05	0.000257	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL2—malaria	1.69e-05	0.000257	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—G6PD—malaria	1.69e-05	0.000257	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—CD36—malaria	1.66e-05	0.000253	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—HBB—malaria	1.66e-05	0.000253	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PKLR—malaria	1.65e-05	0.000251	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SCARB1—malaria	1.63e-05	0.000249	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—HPGDS—malaria	1.62e-05	0.000247	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TNF—malaria	1.62e-05	0.000246	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—DECR1—malaria	1.62e-05	0.000246	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—IL6—malaria	1.6e-05	0.000244	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—HBB—malaria	1.58e-05	0.00024	CbGpPWpGaD
Methotrexate—ABCC1—Disease—G6PD—malaria	1.58e-05	0.00024	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—HPGDS—malaria	1.55e-05	0.000236	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—IL6—malaria	1.52e-05	0.000232	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—CD36—malaria	1.51e-05	0.000229	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—DHFR—malaria	1.5e-05	0.000229	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SCARB1—malaria	1.49e-05	0.000226	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PKLR—malaria	1.48e-05	0.000226	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—G6PD—malaria	1.47e-05	0.000223	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—HBB—malaria	1.46e-05	0.000223	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—malaria	1.45e-05	0.00022	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—DHFR—malaria	1.44e-05	0.000219	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	1.43e-05	0.000217	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SCARB1—malaria	1.43e-05	0.000217	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—HPGDS—malaria	1.42e-05	0.000217	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS2—malaria	1.41e-05	0.000215	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PKLR—malaria	1.41e-05	0.000214	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CD4—malaria	1.39e-05	0.000212	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—DHFR—malaria	1.32e-05	0.000201	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—G6PD—malaria	1.32e-05	0.000201	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SCARB1—malaria	1.31e-05	0.000199	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL6—malaria	1.31e-05	0.000199	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PKLR—malaria	1.3e-05	0.000198	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—CD36—malaria	1.3e-05	0.000198	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—IL2—malaria	1.29e-05	0.000196	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—HPGDS—malaria	1.29e-05	0.000196	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—malaria	1.29e-05	0.000196	CbGpPWpGaD
Methotrexate—PGD—Disease—CD4—malaria	1.27e-05	0.000194	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—G6PD—malaria	1.26e-05	0.000191	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DHODH—malaria	1.25e-05	0.00019	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—malaria	1.24e-05	0.000188	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.23e-05	0.000187	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—malaria	1.23e-05	0.000187	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—DHFR—malaria	1.19e-05	0.000181	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SCARB1—malaria	1.18e-05	0.00018	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—G6PD—malaria	1.16e-05	0.000177	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CD36—malaria	1.15e-05	0.000176	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—malaria	1.14e-05	0.000173	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS2—malaria	1.13e-05	0.000172	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.13e-05	0.000172	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CD36—malaria	1.13e-05	0.000172	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—HPGDS—malaria	1.12e-05	0.00017	CbGpPWpGaD
Methotrexate—ABCC1—Disease—DHFR—malaria	1.12e-05	0.00017	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS2—malaria	1.11e-05	0.000168	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DHODH—malaria	1.09e-05	0.000166	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC4A1—malaria	1.06e-05	0.000162	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—DHFR—malaria	1.04e-05	0.000158	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—malaria	1.04e-05	0.000158	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SCARB1—malaria	1.03e-05	0.000156	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CD36—malaria	1.03e-05	0.000156	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—HPGDS—malaria	1.01e-05	0.000153	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS2—malaria	1.01e-05	0.000153	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DECR1—malaria	9.98e-06	0.000152	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—malaria	9.65e-06	0.000147	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IL2—malaria	9.62e-06	0.000146	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—HPGDS—malaria	9.57e-06	0.000146	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—DHFR—malaria	9.34e-06	0.000142	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CD36—malaria	9.34e-06	0.000142	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC4A1—malaria	9.3e-06	0.000142	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SCARB1—malaria	9.25e-06	0.000141	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HBB—malaria	9.03e-06	0.000137	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CD36—malaria	8.95e-06	0.000136	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—DHFR—malaria	8.88e-06	0.000135	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—HPGDS—malaria	8.86e-06	0.000135	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SCARB1—malaria	8.79e-06	0.000134	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DECR1—malaria	8.75e-06	0.000133	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL2—malaria	8.45e-06	0.000129	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD4—malaria	8.39e-06	0.000128	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—DHFR—malaria	8.22e-06	0.000125	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CD36—malaria	8.21e-06	0.000125	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD4—malaria	8.2e-06	0.000125	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SCARB1—malaria	8.14e-06	0.000124	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PKLR—malaria	8.05e-06	0.000122	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HBB—malaria	7.91e-06	0.00012	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—CD36—malaria	7.77e-06	0.000118	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—malaria	7.52e-06	0.000114	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD4—malaria	7.46e-06	0.000113	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CD36—malaria	7.41e-06	0.000113	CbGpPWpGaD
Methotrexate—ALB—Metabolism—G6PD—malaria	7.17e-06	0.000109	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	7.08e-06	0.000108	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PKLR—malaria	7.05e-06	0.000107	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—malaria	6.88e-06	0.000105	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CD36—malaria	6.45e-06	9.82e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS2—malaria	6.39e-06	9.72e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—G6PD—malaria	6.28e-06	9.56e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	6.06e-06	9.22e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CD36—malaria	5.8e-06	8.83e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS2—malaria	5.7e-06	8.67e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CD36—malaria	5.52e-06	8.39e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HPGDS—malaria	5.47e-06	8.32e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CD36—malaria	5.11e-06	7.77e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DHFR—malaria	5.07e-06	7.72e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SCARB1—malaria	5.02e-06	7.64e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HPGDS—malaria	4.79e-06	7.29e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—malaria	4.54e-06	6.91e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DHFR—malaria	4.45e-06	6.77e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—malaria	4.43e-06	6.75e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SCARB1—malaria	4.4e-06	6.7e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2—malaria	4.35e-06	6.63e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD4—malaria	4.22e-06	6.42e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—malaria	4.03e-06	6.14e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CD36—malaria	3.15e-06	4.8e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CD36—malaria	2.76e-06	4.2e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—malaria	2.28e-06	3.47e-05	CbGpPWpGaD
